CD274 and breast carcinoma: PD-L1 expression has been associated with clinical benefit to ICIs and outcomes can be stratified by PD-L1 expression in multiple solid tumors, including head and neck squamous cell cancers, non-small cell lung cancers, and breast carcinomas.